Charlotte Robinson

DocwireNews

Hyperkalemia is a known risk factor for developing cardiac rhythm disturbances and sudden cardiac death. Chronic kidney disease (CKD) is also a risk factor for cardiovascular problems. The prevalence of hyperkalemia in patients with CKD has varied greatly among studies. Hyperkalemia prevalence specific to patients at the renal clinic at Inkosi Albert Luthuli Central Hospital (IALCH) had not been previously studied, so Alain Assounga and Tasmeen Bux conducted research to fill this gap.Their study not only examined the prevalence of hyperkalemia in patients at the IALCH renal clinic but the degree of hyperkalemia severity. The pair also assessed demographic and other variables for an association with hyperkalemia. Results were presented at the International Society of Nephrology World Congress of Nephrology 2024.&nbsp;The retrospective review included 200 outpatients at the clinic, most of whom were female (n=120, 60%). Hyperkalemia prevalence was 16.0% overall, 7.69% in those with stage 3 CKD, 20.5% in those with stage 4 CKD, and 17.3% in those with stage 5 CKD. There were no statistically significant associations between hyperkalemia and demographic variables, but there was a significant association with the use of sodium polystyrene sulfonate.CKD is a serious and growing problem and hyperkalemia worsens it. Therefore, pharmacological means to manage hyperkalemia should be weighed against the potential for hyperkalemia-associated complications. Potassium-lowering agents are an option to consider for management of cardiovascular issues within the context of hyperkalemia in CKD.Source: <a href="https://doi.org/10.1016/j.ekir.2024.02.029" target="_blank" rel="noopener">KI Reports</a>

Jordana Jampel

Positive Preliminary Results From Phase 1 Trial of Dopaminergic Neuron Graft for Parkinson’s Disease

Dementia

Bradley Warady, MD

Joel M. Topf, MD, FACP

2025 Hume Award Winner Is Dedicated to Children’s Care

NKF Spring Clinical Meetings 2025

Distant Brain Metastases in Cutaneous Melanoma May Be Mitigated With Multiple Pathway Inhibitors

Melanoma

Latest News

Hyperkalemia Prevalence, Management With CKD at a Clinic in Durban, South Africa

WCN 2024

Researchers studied the prevalence of hyperkalemia in patients with chronic kidney disease at a facility in Durban, South Africa.

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe